Presentation on theme: "MICS3 Data Analysis and Report Writing"— Presentation transcript:
1MICS3 Data Analysis and Report Writing MalariaMICS3 Data Analysis and Report Writing
2BackgroundAn estimated million clinical malaria cases and more than one million malaria deaths occur each year, with 90% of these deaths in Sub-Saharan Africa.Repeated episodes of fever and anemia take a toll on a child’s mental and physical development - impairing their education and their growth into productive adults.Pregnant women and their unborn children are also particularly vulnerable to malaria, which is a major cause of low birth weight, anemia and infant death.
3International Goals & Targets Have halted and begun to reverse the incidence of malaria and other major diseasesReduce by one half the burden of disease associated with malaria and ensure that 60% of all people at risk of malaria, especially children and women, sleep under insecticide-treated bednets
4List of Indicators Household availability of ITNs or any net Children under five sleeping under an ITNMalaria treatment for children under fiveIntermittent preventive malaria treatment
5Definition of Indicators Household Availability of ITNs or Any NetPercentage of households with at least oneinsecticide-treated net (or any net)Numerator:Number of households with at least one mosquito net,either permanently treated or treated within the previous12 months (or any net)Denominator:Number of households surveyed
6Table CH.10: Availability of ITNs Tabulation PlanTable CH.10: Availability of ITNs
7Definition of Indicators Children Under-Five Sleeping Under ITNsPercentage of children under five sleepingunder an insecticide-treated netNumerator:Number of children aged 0-59 months that slept under andinsecticide-treated net the previous nightDenominator:Number of children aged 0-59 months surveyed
8Definition of Indicators Malaria Treatment in Children Under-FivePercentage of children under five with reportedfever receiving antimalarialsNumerator:Number of children aged 0-59 months reported to havefever in the 2 weeks prior to the survey that were treatedwith an appropriate antimalarial within 24 hours of onsetof symptomsDenominator:Number of children aged 0-59 months surveyed that were reported to have fever in the 2 weeks prior to the survey
9Methodological Issues Insecticide-treated nets include a mosquito net, either permanently treated or treated within the previous 12 months
10Table CH.11: Children sleeping under bednets Tabulation PlanTable CH.11: Children sleeping under bednets
11% children aged 0-59 months sleeping under an ITN ITN Use% children aged 0-59 months sleeping under an ITN
12Methodological Issues Appropriate antimalarial treatment includes SP/Fansidar, Chloroquine, Amodiaquine, Quinine, Artemisinin-based combinations or other antimalarials (not paracetamol, aspirin or ibuprofen) given same day or next dayComparability issue since most surveys did not consider timing of anti-malarial treatment.Growing resistance to Chloroquine and SP/Fansidar treatment in some areas, which reduces the effectiveness of those drugs.Changes in drug policies for anti-malarial treatment.
14Methodological Issues Percentages given various antimalarials will not add to 100 since children may have been given more than one type of drugUse of GPS (geocoding) to identify malarious parts of countries.
15Methodological Issues Issue of timing of antimalarial treatment:any time v. same day/next day
17% children aged 0-59 months with fever receiving antimalarials Antimalarial Use% children aged 0-59 months with fever receiving antimalarials
18Definition of Indicators Intermittent Preventive Malaria TreatmentPercentage of pregnant women receivingintermittent preventive malaria treatment (IPT)Numerator:Number of women receiving appropriate intermittentmedication to prevent malaria (defined as at least 2 dosesof SP/Fansidar) during the last pregnancy leading to a livebirth within the 2 years prior to the surveyDenominator:Number of women who have had a live birth within the 2 years prior to the survey
19Methodological Issues Note that if the percentage of pregnant women receiving SP/Fansidar an unknown number of times is less than 1% this column may be omitted from the table
20CH.13: Intermittent preventive treatment for malaria Tabulation PlanCH.13: Intermittent preventive treatment for malaria